688238 和元生物
午间休市 06-30 11:29:35
资讯
新帖
简况
每周股票复盘：和元生物（688238）2026年力争完成C证取证
证券之星 · 06-20
每周股票复盘：和元生物（688238）2026年力争完成C证取证
【私募调研记录】天戈投资调研和元生物、初灵信息
证券之星 · 06-19
【私募调研记录】天戈投资调研和元生物、初灵信息
和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%
证券之星 · 06-02
和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%
每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过
证券之星 · 05-17
每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过
和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%
证券之星 · 05-14
和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%
每周股票复盘：和元生物（688238）将召开2025年年度股东会
证券之星 · 05-10
每周股票复盘：和元生物（688238）将召开2025年年度股东会
和元生物（688238）披露2025年年度股东会会议资料，5月8日股价下跌0.75%
证券之星 · 05-08
和元生物（688238）披露2025年年度股东会会议资料，5月8日股价下跌0.75%
每周股票复盘：和元生物（688238）股东户数增6.65%，一季度净利同比上升10.75%
证券之星 · 05-02
每周股票复盘：和元生物（688238）股东户数增6.65%，一季度净利同比上升10.75%
和元生物（688238）披露2025年度持续督导工作现场检查报告，4月28日股价下跌2.89%
证券之星 · 04-28
和元生物（688238）披露2025年度持续督导工作现场检查报告，4月28日股价下跌2.89%
图解和元生物一季报：第一季度单季净利润同比增长10.75%
证券之星 · 04-28
图解和元生物一季报：第一季度单季净利润同比增长10.75%
每周股票复盘：和元生物（688238）2025年归母净利润亏损收窄至-2.35亿元
证券之星 · 04-26
每周股票复盘：和元生物（688238）2025年归母净利润亏损收窄至-2.35亿元
股市必读：和元生物年报 - 第四季度单季净利润同比增长44.75%
证券之星 · 04-22
股市必读：和元生物年报 - 第四季度单季净利润同比增长44.75%
和元生物(688238)3月31日股东户数1.49万户，较上期增加6.65%
证券之星 · 04-21
和元生物(688238)3月31日股东户数1.49万户，较上期增加6.65%
和元生物（688238）披露2025年度内部控制审计报告，4月20日股价上涨2.14%
证券之星 · 04-20
和元生物（688238）披露2025年度内部控制审计报告，4月20日股价上涨2.14%
和元生物(688238.SH)发布2025年度业绩，归母净亏损2.35亿元
智通财经网 · 04-20
和元生物(688238.SH)发布2025年度业绩，归母净亏损2.35亿元
股市必读：和元生物（688238）3月23日收盘跌10.45%，主力净流出286.12万元
证券之星 · 03-24
股市必读：和元生物（688238）3月23日收盘跌10.45%，主力净流出286.12万元
每周股票复盘：和元生物（688238）完成名称工商变更
证券之星 · 03-08
每周股票复盘：和元生物（688238）完成名称工商变更
和元生物新注册《基于深度学习的AAV高通量筛选软件V1.0》项目的软件著作权
证券之星 · 03-07
和元生物新注册《基于深度学习的AAV高通量筛选软件V1.0》项目的软件著作权
和元生物最新公告：公司名称变更完成工商登记并换发营业执照
证券之星 · 03-02
和元生物最新公告：公司名称变更完成工商登记并换发营业执照
每周股票复盘：和元生物（688238）2025年净亏2.207亿
证券之星 · 03-01
每周股票复盘：和元生物（688238）2025年净亏2.207亿
加载更多
公司概况
公司名称：
上海和元生物技术(集团)股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-03-22
主营业务：
上海和元生物技术(集团)股份有限公司的主营业务是各类细胞和基因治疗CRO服务及CDMO服务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、新药Pre-IND服务、新药Post-IND服务、再生医学制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。
发行价格：
13.23
{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":5.39,"timestamp":1782790175000,"preClose":5.48,"halted":0,"volume":8319823,"delay":0,"changeRate":-0.0164,"floatShares":641000000,"shares":649000000,"eps":-0.3524,"marketStatus":"午间休市","change":-0.09,"latestTime":"06-30 11:29:35","open":5.46,"high":5.63,"low":5.35,"amount":45607900,"amplitude":0.0511,"askPrice":5.4,"askSize":130,"bidPrice":5.39,"bidSize":38,"shortable":0,"etf":0,"ttmEps":-0.3524,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782795600000},"marketStatusCode":3,"adr":0,"adjPreClose":5.48,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782783000000,1782790200000],[1782795600000,1782802800000]],"highLimit":6.03,"lowLimit":4.93,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":2.62,"roa":"--","roe":"--","epsLYR":-0.37,"committee":0.628304,"marketValue":3498000000,"turnoverRate":0.013,"status":1,"floatMarketCap":3456000000},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2644065874","title":"每周股票复盘：和元生物（688238）2026年力争完成C证取证","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065874?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:48","pubTimestamp":1781894891,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，和元生物报收于5.55元，较上周的5.35元上涨3.74%。本周，和元生物6月18日盘中最高价报5.7元。和元生物当前最新总市值36.02亿元，在医疗服务板块市值排名37/51，在两市A股市值排名3973/5206。本周关注点来自机构调研要点：公司力争2026年顺利完成药品生产许可证（C证）取证。来自机构调研要点：2026年第一季度，公司累计新增CDMO业务订单超过5,600万元。截至2026年一季度末，累计协助客户获得国内外IND批件70个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644032133","title":"【私募调研记录】天戈投资调研和元生物、初灵信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2644032133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644032133?lang=zh_cn&edition=full","pubTime":"2026-06-19 08:01","pubTimestamp":1781827266,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月18日披露的机构调研信息，知名私募天戈投资近期对2家上市公司进行了调研，相关名单如下：1）和元生物 调研纪要：公司正稳步推进药品生产许可证（C证）申请，力争2026年完成取证。2025年中国CGT领域融资总额约21.78亿美元，同比增长237.15%。公司参与设立5亿元规模CGT产业并购基金，拟出资不超1亿元。公司业务范围包括投资管理、资产管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026061900004833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0090","BK0216","BK0148","BK0028","BK0111","300250","BK0231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911548","title":"和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911548","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640911548?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:44","pubTimestamp":1780393482,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，和元生物报收于6.11元，较前一交易日上涨0.49%，最新总市值为39.66亿元。该股当日开盘6.08元，最高6.27元，最低6.01元，成交额达1.01亿元，换手率为2.56%。近日，和元生物披露《关于董事会秘书变更及高级管理人员变动的公告》。公告显示，公司董事会于2026年5月29日收到副总经理、董事会秘书徐鲁媛女士，副总经理殷珊女士、吴钦斌女士的书面辞呈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200034896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636624300","title":"每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2636624300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636624300?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:47","pubTimestamp":1778964429,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，和元生物报收于6.32元，较上周的6.65元下跌4.96%。本周，和元生物5月11日盘中最高价报6.84元。5月15日盘中最低价报6.27元。本周关注点公司公告汇总：和元生物2025年年度股东会于2026年5月13日召开，各项议案均获通过。公司公告汇总上海市金茂律师事务所就上海和元生物技术(集团)股份有限公司2025年年度股东会的召集、召开程序、出席会议人员资格、表决程序及表决结果出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635718766","title":"和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635718766","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635718766?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:49","pubTimestamp":1778752156,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，和元生物报收于6.39元，较前一交易日下跌2.44%，最新总市值为41.47亿元。该股当日开盘6.54元，最高6.63元，最低6.38元，成交额达6020.66万元，换手率为1.46%。和元生物于近日披露《2025年年度股东会决议公告》。会议表决程序合法，所有议案均获通过，无被否决议案。中小投资者对部分议案进行了单独计票，关联股东对关联交易等相关议案回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400033828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634962414","title":"每周股票复盘：和元生物（688238）将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634962414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634962414?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:30","pubTimestamp":1778351429,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，和元生物报收于6.65元，较上周的6.79元下跌2.06%。本周，和元生物5月6日盘中最高价报6.91元。5月8日盘中最低价报6.58元。和元生物当前最新总市值43.16亿元，在医疗服务板块市值排名39/51，在两市A股市值排名3895/5200。会议采取现场与网络投票相结合方式召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633313034","title":"和元生物（688238）披露2025年年度股东会会议资料，5月8日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633313034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633313034?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:35","pubTimestamp":1778232959,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，和元生物报收于6.65元，较前一交易日下跌0.75%，最新总市值为43.16亿元。该股当日开盘6.69元，最高6.69元，最低6.58元，成交额达6261.9万元，换手率为1.47%。公司于2026年5月8日披露《2025年年度股东会会议资料》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625827","title":"每周股票复盘：和元生物（688238）股东户数增6.65%，一季度净利同比上升10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625827","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625827?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:40","pubTimestamp":1777675222,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，和元生物报收于6.79元，较上周的6.66元上涨1.95%。本周，和元生物4月27日盘中最高价报6.93元。本周关注点股本股东变化：股东户数较12月31日增加6.65%，达1.49万户。业绩披露要点：一季度归母净利润-5308.48万元，同比上升10.75%。公司公告汇总：2025年净利润为-32,181.30万元，较上年减亏。户均持股数量由上期的4.64万股减少至4.35万股，户均持股市值为29.17万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630305219","title":"和元生物（688238）披露2025年度持续督导工作现场检查报告，4月28日股价下跌2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630305219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630305219?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:16","pubTimestamp":1777374960,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，和元生物报收于6.71元，较前一交易日下跌2.89%，最新总市值为43.55亿元。公司于近日披露《国泰海通证券股份有限公司关于上海和元生物技术（集团）股份有限公司2025年度持续督导工作现场检查报告》。公告显示，国泰海通证券股份有限公司对和元生物2025年度持续督导工作进行了现场检查，检查内容包括公司治理、信息披露、募集资金使用、关联交易、对外担保、重大对外投资等方面。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630312950","title":"图解和元生物一季报：第一季度单季净利润同比增长10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630312950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630312950?lang=zh_cn&edition=full","pubTime":"2026-04-28 03:52","pubTimestamp":1777319566,"startTime":"0","endTime":"0","summary":"证券之星消息，和元生物2026年一季报显示，一季度公司主营收入5054.05万元，同比下降4.37%；归母净利润-5308.48万元，同比上升10.75%；扣非净利润-5401.22万元，同比上升9.36%；负债率32.07%，投资收益-42.0万元，财务费用-117.61万元，毛利率-23.85%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800010957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630580709","title":"每周股票复盘：和元生物（688238）2025年归母净利润亏损收窄至-2.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630580709","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630580709?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:31","pubTimestamp":1777156266,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，和元生物报收于6.66元，较上周的7.0元下跌4.86%。本周，和元生物4月20日盘中最高价报7.22元。业绩披露要点：2025年归母净利润为-2.35亿元，同比上升26.96%。股本股东变化股东户数变动截至2026年3月31日，和元生物股东户数为1.49万户，较2025年12月31日增加931户，增幅6.65%。户均持股数量由4.64万股降至4.35万股，户均持股市值为29.17万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629705417","title":"股市必读：和元生物年报 - 第四季度单季净利润同比增长44.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629705417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629705417?lang=zh_cn&edition=full","pubTime":"2026-04-22 02:40","pubTimestamp":1776796820,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年3月31日股东户数环比增长6.65%，户均持股数量下降至4.35万股，表明筹码趋于分散。股本股东变化股东户数变动近日和元生物披露，截至2026年3月31日公司股东户数为1.49万户，较12月31日增加931.0户，增幅为6.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200006413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629814530","title":"和元生物(688238)3月31日股东户数1.49万户，较上期增加6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629814530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629814530?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:13","pubTimestamp":1776762819,"startTime":"0","endTime":"0","summary":"证券之星消息，近日和元生物披露，截至2026年3月31日公司股东户数为1.49万户，较12月31日增加931.0户，增幅为6.65%。户均持股数量由上期的4.64万股减少至4.35万股，户均持股市值为29.17万元。在医疗服务行业个股中，和元生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.57万户。从股价来看，2025年12月31日至2026年3月31日，和元生物区间涨幅为0.75%，在此期间股东户数增加931.0户，增幅为6.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100038683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628763729","title":"和元生物（688238）披露2025年度内部控制审计报告，4月20日股价上涨2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628763729","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628763729?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:14","pubTimestamp":1776694463,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，和元生物报收于7.15元，较前一交易日上涨2.14%，最新总市值为46.41亿元。该股当日开盘6.99元，最高7.22元，最低6.96元，成交额达6774.23万元，换手率为1.48%。近日，和元生物发布《2025年度内部控制审计报告》。公告显示，天健会计师事务所对上海和元生物技术（集团）股份有限公司2025年12月31日的财务报告内部控制有效性进行了审计。同时披露了内部控制的固有局限性，并明确了企业与注册会计师的责任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000036686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628374179","title":"和元生物(688238.SH)发布2025年度业绩，归母净亏损2.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628374179","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628374179?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:24","pubTimestamp":1776680650,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和元生物(688238.SH)披露2025年年度报告，报告期公司实现营收2.68亿元，同比增长7.88%;归属于上市公司股东的净利润亏损2.35亿元，同比收窄;扣非净利润亏损2.46亿元，同比收窄;基本每股收益-0.370元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621814680","title":"股市必读：和元生物（688238）3月23日收盘跌10.45%，主力净流出286.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621814680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621814680?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:02","pubTimestamp":1774296141,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，和元生物报收于6.17元，下跌10.45%，换手率3.97%，成交量25.46万手，成交额1.63亿元。交易信息汇总股价提醒3月23日和元生物收盘报6.17元，跌10.45%，当日成交2546.23万元。前10个交易日资金流向显示，主力资金累计净流出7107.86万元，股价累计下跌20.16%；融资余额累计减少1297.52万元，融券余量累计增加0股。资金流向3月23日主力资金净流出286.12万元，占总成交额1.76%；游资资金净流入1638.8万元，占总成交额10.06%；散户资金净流出1352.68万元，占总成交额8.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617668427","title":"每周股票复盘：和元生物（688238）完成名称工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617668427?lang=zh_cn&edition=full","pubTime":"2026-03-08 01:55","pubTimestamp":1772906113,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，和元生物报收于7.71元，较上周的7.48元上涨3.07%。公司公告汇总关于公司名称变更完成工商登记并换发营业执照的公告上海和元生物技术（集团）股份有限公司于2026年2月4日和2月26日分别召开第四届董事会第六次会议及2026年第一次临时股东会，审议通过变更公司名称、修订《公司章程》并办理工商变更登记的议案。截至公告日，公司已实缴出资5,400万元。本次减资已完成工商变更登记，不会对公司财务状况和经营产生不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632375","title":"和元生物新注册《基于深度学习的AAV高通量筛选软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632375","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632375?lang=zh_cn&edition=full","pubTime":"2026-03-07 01:55","pubTimestamp":1772819716,"startTime":"0","endTime":"0","summary":"证券之星消息，近日和元生物新注册了《基于深度学习的AAV高通量筛选软件V1.0》项目的软件著作权。今年以来和元生物新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2321.34万元，同比减20.18%。通过天眼查大数据分析，上海和元生物技术（集团）股份有限公司共对外投资了12家企业，参与招投标项目73次；财产线索方面有商标信息243条，专利信息67条，著作权信息11条；此外企业还拥有行政许可72个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700000215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616338090","title":"和元生物最新公告：公司名称变更完成工商登记并换发营业执照","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616338090?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:20","pubTimestamp":1772446804,"startTime":"0","endTime":"0","summary":"和元生物(688238.SH)公告称，公司名称变更完成工商登记并换发营业执照，中文名称变更为“上海和元生物技术（集团）股份有限公司”，证券简称及公司证券代码保持不变。据悉，此次名称中增加“集团”字样，标志着和元生物正向集团化、规模化、国际化的战略方向迈进，也体现了公司打造以细胞和基因治疗为核心的国际化产业集团的决心。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200028341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616845579","title":"每周股票复盘：和元生物（688238）2025年净亏2.207亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845579?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:42","pubTimestamp":1772304131,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，和元生物报收于7.48元，较上周的7.09元上涨5.5%。本周，和元生物2月26日盘中最高价报7.6元。本周关注点来自业绩披露要点：和元生物2025年归属净利润亏损2.207亿元，同比减亏31.41%。公司公告汇总和元生物发布2025年度业绩快报，营业总收入26,766.34万元，同比增长7.86%；归属于母公司所有者的净利润为-22,071.57万元，较上年同期减少亏损10,109.73万元。期末总资产210,451.45万元，较期初下降7.89%；归属于母公司的所有者权益142,247.66万元，较期初下降18.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782794891013,"stockEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":-0.0568},{"period":"3month","weight":-0.1833},{"period":"6month","weight":-0.1772},{"period":"1year","weight":-0.0759},{"period":"ytd","weight":-0.1772}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":0.0013},{"period":"3month","weight":0.0468},{"period":"6month","weight":0.0265},{"period":"1year","weight":0.1897},{"period":"ytd","weight":0.0265}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海和元生物技术(集团)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"14931人(较上一季度增加6.65%)","perCapita":"42940股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":" 上海和元生物技术(集团)股份有限公司的主营业务是各类细胞和基因治疗CRO服务及CDMO服务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、新药Pre-IND服务、新药Post-IND服务、再生医学制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}